Growth Metrics

Soleno Therapeutics (SLNO) Divestments: 2016-2017

Historic Divestments for Soleno Therapeutics (SLNO) over the last 1 years, with Sep 2017 value amounting to $717,000.

  • Soleno Therapeutics' Divestments rose 35750.00% to $717,000 in Q3 2017 from the same period last year, while for Sep 2017 it was $709,115, marking a year-over-year change of. This contributed to the annual value of -$172,000 for FY2018, which is 124.02% down from last year.
  • As of Q3 2017, Soleno Therapeutics' Divestments stood at $717,000, which was up 23,800.00% from $3,000 recorded in Q2 2017.
  • Soleno Therapeutics' 5-year Divestments high stood at $717,000 for Q3 2017, and its period low was -$6,885 during Q4 2016.
  • Moreover, its 2-year median value for Divestments was $2,000 (2016), whereas its average is $142,223.
  • Data for Soleno Therapeutics' Divestments shows a peak YoY surged of 35,750.00% (in 2017) over the last 5 years.
  • Over the past 2 years, Soleno Therapeutics' Divestments (Quarterly) stood at -$6,885 in 2016, then surged by 35,750.00% to $717,000 in 2017.
  • Its Divestments stands at $717,000 for Q3 2017, versus $3,000 for Q2 2017 and -$4,000 for Q1 2017.